![Elizabeth Stoner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Stoner
Directeur/Membre du Conseil chez
IBIO, INC.
Fortune : 98 115 $ au 31/05/2026
Profil
Elizabeth Stoner was the founder of Rhythm Pharmaceuticals, Inc., founded in 2010, where the title held was Chief Medical & Development Officer.
Dr. Stoner was the founder of Allergan GI Corp., founded in 2008, where the title held was Chief Development Officer.
Current jobs include Director at Antiva Biosciences, Inc. since 2023; Independent Director at iBio, Inc. starting in 2026; Director & Chief Development Officer at Vascular Pharmaceuticals, Inc. since 2012; Director at LIB Therapeutics LLC since 2016; Entrepreneur Partner at MPM BioImpact LLC since 2007; and Member-Governors Board at Albert Einstein College of Medicine, Inc. Former jobs include Chief Executive Officer at Semma Therapeutics, Inc. from 2017 to 2018; Chairman at Arovella Therapeutics Ltd. from 2025 to 2026; Director at Metabasis Therapeutics, Inc. from 2009 to 2010; Independent Director at Momenta Pharmaceuticals, Inc. from 2007 to 2020; Independent Director at Radius Health, Inc. from 2011 to 2015; Director at Triplet Therapeutics, Inc.; Senior VP-Clinical Sciences & Product Development at Merck & Co., Inc. in 2007; SVP-Global Clinical Development Operations at Merck Research Laboratories Massachusetts LLC from 1985 to 2007; Assistant Professor at Weill Cornell Medical College; and Chief Medical Officer at AlloVir, Inc. Education includes graduate degree from Stony Brook University, undergraduate degree from Ottawa University (Kansas), and doctorate degree conferred in 1977 from Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/11/2025 | 1 920 804 ( 0,16% ) | 98 115 $ | 31/05/2026 |
Postes actifs de Elizabeth Stoner
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 07/05/2026 |
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company dedicated to bringing novel, highly effective and safe therapies for cardiovascular disease | Directeur/Membre du Conseil | 01/01/2016 |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2007 |
Vascular Pharmaceuticals, Inc.
 Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of diabetic nephropathy | Directeur/Membre du Conseil | 01/09/2012 |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Elizabeth Stoner
| Sociétés | Poste | Fin |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Président | 09/02/2026 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2020 |
| ALLOVIRPAR | Directeur Technique/Scientifique/R&D | 01/04/2019 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Elizabeth Stoner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ottawa University (Kansas)
 Ottawa University (Kansas) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of diabetic nephropathy | Health Technology |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company dedicated to bringing novel, highly effective and safe therapies for cardiovascular disease | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
